Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106


Vaccination of rhesus macaques against dengue-2 virus with a plasmid DNA vaccine encoding the viral pre-membrane and envelope genes.

Putnak R, Fuller J, VanderZanden L, Innis BL, Vaughn DW.

Am J Trop Med Hyg. 2003 Apr;68(4):469-76.


Protection against dengue virus by non-replicating and live attenuated vaccines used together in a prime boost vaccination strategy.

Simmons M, Burgess T, Lynch J, Putnak R.

Virology. 2010 Jan 20;396(2):280-8. doi: 10.1016/j.virol.2009.10.023. Epub 2009 Nov 13.


Synergistic neutralizing antibody response to a dengue virus type 2 DNA vaccine by incorporation of lysosome-associated membrane protein sequences and use of plasmid expressing GM-CSF.

Raviprakash K, Marques E, Ewing D, Lu Y, Phillips I, Porter KR, Kochel TJ, August TJ, Hayes CG, Murphy GS.

Virology. 2001 Nov 10;290(1):74-82.


Characterization of antibody responses to combinations of a dengue-2 DNA and dengue-2 recombinant subunit vaccine.

Simmons M, Murphy GS, Kochel T, Raviprakash K, Hayes CG.

Am J Trop Med Hyg. 2001 Nov;65(5):420-6.


Preliminary evaluation of DNA vaccine candidates encoding dengue-2 prM/E and NS1: their immunity and protective efficacy in mice.

Lu H, Xu XF, Gao N, Fan DY, Wang J, An J.

Mol Immunol. 2013 Jun;54(2):109-14. doi: 10.1016/j.molimm.2012.11.007. Epub 2012 Dec 25.


Evaluation of protection induced by a dengue virus serotype 2 envelope domain III protein scaffold/DNA vaccine in non-human primates.

McBurney SP, Sunshine JE, Gabriel S, Huynh JP, Sutton WF, Fuller DH, Haigwood NL, Messer WB.

Vaccine. 2016 Jun 24;34(30):3500-7. doi: 10.1016/j.vaccine.2016.03.108. Epub 2016 Apr 13.


Dengue virus type 1 DNA vaccine induces protective immune responses in rhesus macaques.

Raviprakash K, Porter KR, Kochel TJ, Ewing D, Simmons M, Phillips I, Murphy GS, Weiss WR, Hayes CG.

J Gen Virol. 2000 Jul;81(Pt 7):1659-67.


A dengue virus serotype-1 DNA vaccine induces virus neutralizing antibodies and provides protection from viral challenge in Aotus monkeys.

Kochel TJ, Raviprakash K, Hayes CG, Watts DM, Russell KL, Gozalo AS, Phillips IA, Ewing DF, Murphy GS, Porter KR.

Vaccine. 2000 Jul 15;18(27):3166-73.


An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model.

Robert Putnak J, Coller BA, Voss G, Vaughn DW, Clements D, Peters I, Bignami G, Houng HS, Chen RC, Barvir DA, Seriwatana J, Cayphas S, Garçon N, Gheysen D, Kanesa-Thasan N, McDonell M, Humphreys T, Eckels KH, Prieels JP, Innis BL.

Vaccine. 2005 Aug 15;23(35):4442-52.


Protection of Rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccination.

Sun W, Nisalak A, Gettayacamin M, Eckels KH, Putnak JR, Vaughn DW, Innis BL, Thomas SJ, Endy TP.

J Infect Dis. 2006 Jun 15;193(12):1658-65. Epub 2006 May 9.


A DNA vaccine candidate expressing dengue-3 virus prM and E proteins elicits neutralizing antibodies and protects mice against lethal challenge.

De Paula SO, Lima DM, de Oliveira França RF, Gomes-Ruiz AC, da Fonseca BA.

Arch Virol. 2008;153(12):2215-23. doi: 10.1007/s00705-008-0250-3. Epub 2008 Nov 12.


A chimeric tetravalent dengue DNA vaccine elicits neutralizing antibody to all four virus serotypes in rhesus macaques.

Raviprakash K, Apt D, Brinkman A, Skinner C, Yang S, Dawes G, Ewing D, Wu SJ, Bass S, Punnonen J, Porter K.

Virology. 2006 Sep 15;353(1):166-73. Epub 2006 Jun 30.


Immune response of pregnant cows to bovine rotavirus immunization.

Saif LJ, Smith KL, Landmeier BJ, Bohl EH, Theil KW, Todhunter DA.

Am J Vet Res. 1984 Jan;45(1):49-58.


Induction of neutralizing antibodies and partial protection from viral challenge in Macaca fascicularis immunized with recombinant dengue 4 virus envelope glycoprotein expressed in Pichia pastoris.

Guzmán MG, Rodríguez R, Rodríguez R, Hermida L, Alvarez M, Lazo L, Muné M, Rosario D, Valdés K, Vázquez S, Martinez R, Serrano T, Paez J, Espinosa R, Pumariega T, Guillén G.

Am J Trop Med Hyg. 2003 Aug;69(2):129-34.


Dengue-2 vaccine: viremia and immune responses in rhesus monkeys.

Scott RM, Nisalak A, Eckels KH, Tingpalapong M, Harrison VR, Gould DJ, Chapple FE, Russell PK.

Infect Immun. 1980 Jan;27(1):181-6.


A tetravalent dengue vaccine based on a complex adenovirus vector provides significant protection in rhesus monkeys against all four serotypes of dengue virus.

Raviprakash K, Wang D, Ewing D, Holman DH, Block K, Woraratanadharm J, Chen L, Hayes C, Dong JY, Porter K.

J Virol. 2008 Jul;82(14):6927-34. doi: 10.1128/JVI.02724-07. Epub 2008 May 14.


Vaccine candidates derived from a novel infectious cDNA clone of an American genotype dengue virus type 2.

Blaney JE Jr, Hanson CT, Hanley KA, Murphy BR, Whitehead SS.

BMC Infect Dis. 2004 Oct 4;4:39.


Comparison of plaque- and enzyme-linked immunospot-based assays to measure the neutralizing activities of monoclonal antibodies specific to domain III of dengue virus envelope protein.

Liu L, Wen K, Li J, Hu D, Huang Y, Qiu L, Cai J, Che X.

Clin Vaccine Immunol. 2012 Jan;19(1):73-8. doi: 10.1128/CVI.05388-11. Epub 2011 Nov 23.


Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates.

Guirakhoo F, Pugachev K, Arroyo J, Miller C, Zhang ZX, Weltzin R, Georgakopoulos K, Catalan J, Ocran S, Draper K, Monath TP.

Virology. 2002 Jun 20;298(1):146-59.

Supplemental Content

Support Center